IRIS UniCatt

Miele, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.985
AS - Asia 11.754
EU - Europa 11.235
SA - Sud America 2.187
AF - Africa 281
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 27
Totale 37.509
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.619
SG - Singapore 5.453
DE - Germania 3.247
CN - Cina 2.795
IT - Italia 2.206
BR - Brasile 1.808
SE - Svezia 1.629
VN - Vietnam 991
FR - Francia 824
IE - Irlanda 572
UA - Ucraina 523
GB - Regno Unito 464
FI - Finlandia 431
NL - Olanda 420
ID - Indonesia 401
JP - Giappone 387
IN - India 369
RU - Federazione Russa 255
HK - Hong Kong 248
TR - Turchia 212
KR - Corea 167
BD - Bangladesh 166
AR - Argentina 165
CA - Canada 163
PL - Polonia 143
IQ - Iraq 131
MX - Messico 103
AT - Austria 95
BE - Belgio 88
ZA - Sudafrica 68
ES - Italia 62
CH - Svizzera 57
PK - Pakistan 54
SA - Arabia Saudita 51
EC - Ecuador 48
IR - Iran 48
MA - Marocco 45
CZ - Repubblica Ceca 44
CO - Colombia 37
CL - Cile 34
EG - Egitto 34
KE - Kenya 34
LT - Lituania 34
UZ - Uzbekistan 33
VE - Venezuela 32
PH - Filippine 31
AU - Australia 30
AE - Emirati Arabi Uniti 25
CI - Costa d'Avorio 25
JO - Giordania 22
RO - Romania 22
PY - Paraguay 21
AZ - Azerbaigian 19
EU - Europa 19
JM - Giamaica 19
PT - Portogallo 19
DZ - Algeria 17
NP - Nepal 17
TN - Tunisia 16
IL - Israele 15
PA - Panama 15
CR - Costa Rica 14
MY - Malesia 14
OM - Oman 14
LB - Libano 13
PE - Perù 13
TT - Trinidad e Tobago 13
UY - Uruguay 13
AL - Albania 12
HU - Ungheria 12
BO - Bolivia 11
GR - Grecia 11
DK - Danimarca 10
NZ - Nuova Zelanda 10
KG - Kirghizistan 9
TH - Thailandia 9
DO - Repubblica Dominicana 8
GE - Georgia 8
KZ - Kazakistan 8
BG - Bulgaria 7
HN - Honduras 7
ET - Etiopia 6
LK - Sri Lanka 6
MD - Moldavia 6
SK - Slovacchia (Repubblica Slovacca) 6
SV - El Salvador 6
BH - Bahrain 5
BY - Bielorussia 5
BZ - Belize 5
EE - Estonia 5
GT - Guatemala 5
GY - Guiana 5
NG - Nigeria 5
RE - Reunion 5
SY - Repubblica araba siriana 5
BA - Bosnia-Erzegovina 4
CY - Cipro 4
HR - Croazia 4
KW - Kuwait 4
QA - Qatar 4
Totale 37.433
Salva come PNG Salva come JPEG
Città #
Singapore 2.860
San Jose 1.430
Ashburn 1.345
Chandler 1.092
Dublin 570
Beijing 499
Hefei 483
New York 443
Chicago 391
Rome 379
Tokyo 370
Jakarta 368
Ho Chi Minh City 365
Lauterbourg 339
Milan 325
Frankfurt am Main 324
Los Angeles 324
Jacksonville 292
Dallas 267
Helsinki 254
San Mateo 251
Hanoi 226
Hong Kong 218
Council Bluffs 207
Nanjing 207
Munich 186
Boston 162
Moscow 161
São Paulo 155
Houston 154
Nürnberg 154
Ann Arbor 153
The Dalles 153
Wilmington 151
Seoul 146
Kent 135
Izmir 124
Marseille 118
Princeton 113
Santa Clara 108
Dearborn 107
Cattolica 104
Nuremberg 95
Brussels 87
Seattle 87
Woodbridge 86
Boardman 77
Nanchang 77
Buffalo 72
Brooklyn 70
London 66
Rio de Janeiro 65
Paris 64
Warsaw 62
Atlanta 60
Hyderabad 57
Redmond 55
Guangzhou 54
Tianjin 52
Amsterdam 50
Kraków 50
Baghdad 49
Fairfield 49
Orem 49
Shanghai 48
Turku 48
Redwood City 47
Denver 45
Hebei 45
Montreal 45
Poplar 43
Shenyang 43
Da Nang 42
Stockholm 42
Zurich 42
Dhaka 40
Düsseldorf 39
St Louis 39
Toronto 39
Zhengzhou 39
Bremen 38
Lawrence 38
Vienna 38
Brasília 37
Phoenix 37
Chennai 36
San Francisco 36
Belo Horizonte 34
Brno 34
Kunming 34
Johannesburg 33
Mexico City 32
Lappeenranta 31
Curitiba 30
Hangzhou 30
Mountain View 30
North Bergen 30
Norwalk 30
Washington 30
Changsha 29
Totale 18.999
Salva come PNG Salva come JPEG
Nome #
A multi-society Delphi consensus statement on new fatty liver disease nomenclature 1.284
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) 478
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 456
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 310
A phase II study of sunitinib in advanced hepatocellular carcinoma 270
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 265
13C-methionine breath tests for mitochondrial liver function assessment. 261
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? 258
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 245
13C-breath tests in the study of microsomal liver function 242
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 237
-Hepatic steatosis and vascular disease 235
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
A multi-society Delphi consensus statement on new fatty liver disease nomenclature 219
134C-breath tests in the study of mitochondrial liver function 217
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 214
Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver 213
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 201
Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm 201
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 200
13C-breath tests in the study of microsomial liver function 200
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 198
Assessment of neurological manifestations in hospitalized patients with COVID-19 195
13C-methionine breath tests for mitochondrial liver function assessment 192
Effect of sildenafil on diabetic gastropathy. 190
Liver transplantation in patients with alcoholic liver disease: A retrospective study 189
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 187
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 182
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 179
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 174
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 174
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 174
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 173
Potential use of liver function breath tests in the clinical practice. 172
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 171
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 169
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 167
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 167
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 166
[Helicobacter pylori infection: from gastric to systemic disease] 166
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 166
13C-breath tests in the study of mitochondrial liver function 165
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 165
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 164
Cryoglobulinemia: a true internistic disease? 164
-Fatty liver and drugs 161
[The treatment of hepatocellular carcinoma: an update] 161
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 160
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 158
gastroesophageal reflux disease: facts and uncertaines 154
Intrafamilial transmission of hepatitis C virus in Italy: a systematic review 152
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 152
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 152
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 151
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 148
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 148
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 148
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 146
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 146
An Attempt of Specific Desensitizing Treatment with Gliadin in Coleliac Disease 145
Tromboembolism and breast cancer: the hidden risk for patient and physician 145
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease 145
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 144
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 142
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 141
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 141
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 140
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 140
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic Fatty liver disease 140
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 140
Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy 139
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial 138
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 138
-Nonalcoholic fatty liver disease: defining a common problem 138
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 135
Braised liver with herbs: the risks of naturopathic hepatoprotection. 133
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 133
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 132
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 132
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 132
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 131
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 131
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis 128
Alcoholic and nonalcoholic forms of fatty liver disease. 128
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 128
Availability of a Web and Smartphone Application to Stratify the Risk of of Early Allograft Failure Requiring Liver Retransplantation 127
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 127
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. 126
Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia 125
The role of elastography in non-Alcoholic fatty liver disease 125
Effect of Low-Dose Alcohol Consumption on Chronic Liver Disease 124
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 124
A case of variant angina in a patient under chronic treatment with sorafenib 123
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 123
Gender affects 13C-ketoisocaproic acid breath test 122
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 122
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 122
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 120
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 120
URINARY LITHOGENIC PROFILE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 120
Totale 18.193
Salva come PNG Salva come JPEG
Categoria #
all - tutte 164.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021244 0 0 0 0 0 0 0 0 0 0 218 26
2021/20221.565 46 112 49 178 111 35 24 235 57 98 295 325
2022/20234.189 436 420 240 452 424 566 283 334 448 271 237 78
2023/20243.093 238 800 109 176 159 337 222 106 45 216 266 419
2024/20257.573 151 124 527 243 551 304 319 620 1.308 718 1.507 1.201
2025/202615.788 2.480 608 1.152 1.780 2.533 1.359 2.534 804 1.229 1.118 191 0
Totale 38.031